Published in Hepatitis Weekly, November 22nd, 2004
The addition of this laboratory testing service enables Covance to provide in-region, near real-time, NAT testing required by pharmaceutical and biotechnology companies to support their clinical trials in viral infectious diseases, such as HIV and hepatitis. The use of nucleic acid amplification test methodologies, such as polymerase chain reaction (PCR), is faster than other screening tests, because it detects viral genes rather than antibodies or...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly